Ovarian cancer trials in Singapore
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Where
- Singapore
- Age
- 18 years and over
- People
- 1,630 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213804 · EU 2025-522255-25-00 - Phase 3Taking peopleStudy of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Where
- Singapore
- Age
- 18 years and over
- People
- 582 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06819007 · EU 2024-516982-35-00 - Phase 1/2Taking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Kent Ridge, Singapore
- Age
- 12 years and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - Phase 2Taking peopleNiraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer
- Where
- Singapore
- Age
- 18 years to 99 years
- People
- 390 worldwide
- Run by
- ARCAGY/ GINECO GROUP
See details and how to joinNCT05183984 · EU 2023-504166-37-00 - Phase 2Taking peopleCATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Where
- Singapore
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- TORL Biotherapeutics, LLC
See details and how to joinNCT06690775 · EU 2024-517190-24-00 - Phase 1Taking peopleETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers
- Where
- Singapore
- Age
- 21 years to 99 years
- People
- 16
- Run by
- National University Hospital, Singapore
See details and how to joinNCT06513624